Aberrant DNA methylations in chondrosarcoma

Chondrosarcoma (CS) is the second most common primary malignant bone tumor. Unlike other bone tumors, CS is highly resistant to conventional chemotherapy and radiotherapy, thus resulting in poor patient outcomes. There is an urgent need to establish alternative therapies for CS. However, the etiolog...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Epigenomics
Päätekijät: Liu, Pei, Shen, Jacson K, Xu, Jianzhong, Trahan, Carol A, Hornicek, Francis J, Duan, Zhenfeng
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Future Medicine Ltd 2016
Aiheet:
Special Report
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC5289043/
https://ncbi.nlm.nih.gov/pubmed/27686001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/epi-2016-0071
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia